Get startedLog in
    Picture of Genmab A/S logo

    GMAB — Genmab A/S Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Genmab A/S, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:
    fx
    Final
    fx
    Final
    fx
    Final
    fx
    Final
    fx
    Final
    Net Income/Starting Line9036339948181,329
    Depreciation
    Amortisation
    Non-Cash Items93.1-109-33.839.2-236
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-51.8-209-459171-26.3
    Change in Accounts Receivable
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities9843545531,0711,127
    Capital Expenditures-46.9-40.1-44.8-54.6-44.1
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-313-113-345-132-1,393
    Acquisition of Business
    Sale/Maturity of Investment
    Purchase of Investments
    Cash from Investing Activities-360-153-390-186-1,437
    Financing Cash Flow Items-3.82-7.95-12.4-14.9-15.8
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities10.9-66.8-112-88-568
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash567270132722-726